Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-09

FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ABSORICA LD (isotretinoin) submitted by Sun Pharmaceutical Industries, expanding/altering the product's labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABSORICA LD (isotretinoin)

Snippet

SUPPL AP for ABSORICA LD (ISOTRETINOIN)